Pharmacogenics

What’s the right treatment for me?

Mental Health DNA InsightIf you’ve ever tried a medicine that didn’t work or caused you side effects, you know that medicines don’t work the same for everyone. “Pharmacogenics uses information about a person’s genetic makeup, or genome to choose the drugs and drug doses that are likely to work best for that particular person”1

The good news is that Bridgeport Behavioral Health is working with companies like AssureRX Health, Inc. and Pathway Genomics® to provide analysis of your genes to select the medications that are more likely to work better for you.

AssureRX Health GeneSight® tests are available for:

  • depression, anxiety, bipolar disorder, schizophrenia or other behavioral health conditions
  • acute and chronic pain
  • attention deficit hyperactivity disorder (ADHD), attention deficit disorder (ADD) and narcolepsy
  • folic acid (folate) deficiency

Mental Health DNA Insight<sup>&#8480;</sup> ReportsMental Health DNA Insight from Pathway Genomics analyzes a patient’s DNA to identify genetic variants that affect the metabolism and efficacy of psychiatric medications. Genetic research suggests that categorizing individuals based on genotypes will make the pharmacologic treatment of psychiatric illnesses more predictable and effective. Mental Health DNA Insight can help a physician predict a patient’s response to more than 40 common antidepressants, mood stabilizers and antipsychotic medications. The report provides outcomes in a clear color-coded chart.

Contact us for more information!

« Back to Genetic Testing

  1. National Institutes of Health
    National Human Genome Research Institute